Literature DB >> 32169720

l-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells.

Marcello Rattazzi1, Maristella Donato2, Elisa Bertacco3, Renato Millioni4, Cinzia Franchin5, Cinzia Mortarino6, Elisabetta Faggin3, Chiara Nardin7, Riccardo Scarpa7, Francesco Cinetto7, Carlo Agostini7, Nicola Ferri2, Paolo Pauletto8, Giorgio Arrigoni5.   

Abstract

BACKGROUND AND AIMS: Reduced bioavailability of nitric oxide (NO) has been implicated in the pathogenesis of calcific aortic stenosis. Herein, we investigated the effects of l-Arginine, the main precursor of NO, on the osteogenic differentiation of aortic interstitial valve cells (VICs).
METHODS: We isolated a clonal population of bovine VICs that expresses osteogenic markers and induces calcification of collagen matrix after stimulation with endotoxin (LPS 500 ng/mL). VICs were treated in vitro with different combinations of LPS ± l-Arginine (50 or 100 mM) and cell extracts were collected to perform proteomic (iTRAQ) and gene expression (RT-PCR) analysis.
RESULTS: l-Arginine prevents the over-expression of alkaline phosphatase (ALP, p < 0.001) and reduces matrix calcification (p < 0.05) in VICs treated with LPS. l-Arginine also reduces the over-expression of inflammatory molecules induced by LPS (TNF-alpha, IL-6 and IL-1beta, p < 0.001). The proteomic analysis allowed to identify 49 proteins with an altered expression profile after stimulation with LPS and significantly modified by l-Arginine. These include proteins involved in the redox homeostasis of the cells (i.e. Xanthine Oxidase, Catalase, Aldehyde Oxidase), remodeling of the extracellular matrix (i.e. ADAMTSL4, Basigin, COL3A1) and cellular signaling (i.e. Fibrillin-1, Legumain, S100A13). The RT-PCR analysis confirmed the modifications of Fibrillin-1, ADAMTSL4, Basigin and Xanthine Oxidase, whose expression levels increase after stimulation with LPS and are reduced by l-Arginine (p < 0.05).
CONCLUSIONS: l-Arginine prevents osteogenic differentiation of VICs and reduces matrix calcification. This effect is achieved through the modulation of proteins involved in the cellular redox system, remodeling of extracellular matrix and inflammatory activation of VICs.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aortic valve calcification; Inflammation; L-Arginine; Nitric oxide; Proteomics

Mesh:

Substances:

Year:  2020        PMID: 32169720     DOI: 10.1016/j.atherosclerosis.2020.02.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.

Authors:  Harry Z E Greenberg; Guoan Zhao; Ajay M Shah; Min Zhang
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

Review 2.  Aortic Valve Stenosis and Mitochondrial Dysfunctions: Clinical and Molecular Perspectives.

Authors:  Gaia Pedriali; Giampaolo Morciano; Simone Patergnani; Paolo Cimaglia; Cristina Morelli; Elisa Mikus; Roberto Ferrari; Vincenzo Gasbarro; Carlotta Giorgi; Mariusz R Wieckowski; Paolo Pinton
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

Review 3.  The Complex Interplay of Inflammation, Metabolism, Epigenetics, and Sex in Calcific Disease of the Aortic Valve.

Authors:  Silvia Ferrari; Maurizio Pesce
Journal:  Front Cardiovasc Med       Date:  2022-01-06

4.  Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way.

Authors:  Qiao En; Huang Zeping; Wang Yuetang; Wang Xu; Wang Wei
Journal:  Mol Med       Date:  2021-12-11       Impact factor: 6.354

5.  Bioprosthesis in aortic valve replacement: long-term inflammatory response and functionality.

Authors:  Huitzilihuitl Saucedo-Orozco; Jesus Vargas-Barron; Ricardo Márquez-Velazco; Julio Iván Farjat-Pasos; Karla Susana Martinez-Zavala; Valentin Jiménez-Rojas; Sergio Andres Criales-Vera; Jose Antonio Arias-Godínez; Giovanni Fuentevilla-Alvarez; Veronica Guarner-Lans; Israel Perez-Torres; Gabriela Melendez-Ramirez; Tomas Efrain Sanchez Perez; Maria Elena Soto
Journal:  Open Heart       Date:  2022-08

Review 6.  Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview.

Authors:  Maria Bogdanova; Arsenii Zabirnyk; Anna Malashicheva; Daria Semenova; John-Peder Escobar Kvitting; Mari-Liis Kaljusto; Maria Del Mar Perez; Anna Kostareva; Kåre-Olav Stensløkken; Gareth J Sullivan; Arkady Rutkovskiy; Jarle Vaage
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

Review 7.  Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets.

Authors:  Daniela Maria Tanase; Emilia Valasciuc; Evelina Maria Gosav; Mariana Floria; Claudia Florida Costea; Nicoleta Dima; Ionut Tudorancea; Minela Aida Maranduca; Ionela Lacramioara Serban
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

Review 8.  Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis.

Authors:  Maristella Donato; Nicola Ferri; Maria Giovanna Lupo; Elisabetta Faggin; Marcello Rattazzi
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

9.  Identification of CD34+/PGDFRα+ Valve Interstitial Cells (VICs) in Human Aortic Valves: Association of Their Abundance, Morphology and Spatial Organization with Early Calcific Remodeling.

Authors:  Grzegorz J Lis; Andrzej Dubrowski; Maciej Lis; Bernard Solewski; Karolina Witkowska; Veronika Aleksandrovych; Ewa Jasek-Gajda; Mateusz K Hołda; Krzysztof Gil; Jan A Litwin
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

Review 10.  Towards Personalized Therapy of Aortic Stenosis.

Authors:  Piotr Mazur; Magdalena Kopytek; Michał Ząbczyk; Anetta Undas; Joanna Natorska
Journal:  J Pers Med       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.